<DOC>
	<DOCNO>NCT00301613</DOCNO>
	<brief_summary>This study perform compare efficacy , safety , tolerability relapse MMF v CTX treatment severe HSPN</brief_summary>
	<brief_title>Mycophenolate Mofetil ( MMF ) Versus Intravenous CTX Pulses Treatment Adult Severe HSPN</brief_title>
	<detailed_description>Henoch-Schoenlein purpura nephritis ( HSPN ) massive proteinuria , renal insufficiency crescent formation onset high risk progress end stage renal failure . Though clinical study show steroid combination cyclophosphamide could reduce proteinuria preserve renal function , protocol associate many side effect , effective patient . Recent study show mycophenolic acid ( MPA ) , active metabolite mycophenolate mofetil ( MMF ) , could inhibit multifarious effect endothelial cell , include adhesion molecular expression , neutrophil attachment , IL-6 secretion , process angiogenesis , contribute efficacy MMF treatment vasculitis . Clinical study also show MMF effective treatment lupus nephritis vasculitic lesion . These finding suggest MMF might effective treatment severe HSPN , kind vasculitic lesion . This prospective open-labeled clinical trial study investigate efficiency MMF treatment severe HSPN compare pulse intravenous cyclophosphamide . After 12 month treatment , assess efficacy , safety , tolerability relapse MMF compare cyclophosphamide treatment severe HSPN .</detailed_description>
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Schoenlein-Henoch</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>1650 year Biopsy prove HSP Proteinuria â‰¥ 3.0 g/24hr Scr &lt; 5.0 mg/dl Cytotoxic drug treatment CTX , CsA , MMF morn 1 month3 month prior enrol Pregnancy Active/serious infection Previous diagnose diabetes mellitus type 1 2</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Henoch-Schonlein purpura nephritis Mycophenolate mofetil</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>treatment</keyword>
</DOC>